← SynDRA
ZOTAROLIMUS
SynDRA canonical compound SYN0006030 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | FKBP1A | MTOR |
|---|
| Mechanism of action | mTOR inhibitor |
|---|
| Indication | coronary artery restenosis |
|---|
| Disease area | cardiology |
|---|
All known targets
Mechanisms of action (all sources)
- FKBP1A INHIBITOR
- FK506-binding protein 1A inhibitor
- MTOR inhibitor
- MTOR MODULATOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Cross-references
Synonyms
- ABT-578
- ABT578
- Mdt-4107
- Abt-578
- Zotarolimus (TN)
- ABT 578
- zotarilumus
- H4GXR80IZE
- zotarolimusum
- RefChem:196269
- DTXCID40820906
- MFCD09752954
- Endeavor
- C52H79N5O12
- Zotarolimus, >90%
- UNII-H4GXR80IZE
- Zotarolimus [USAN:INN]
- A 179578
- ZOTAROLIMUS [INN]
- ZOTAROLIMUS [USAN]
- Zotarolimus (ABT-578)
- Zotarolimus; ABT-578
- ZOTAROLIMUS [MART.]
- ZOTAROLIMUS [WHO-DD]
- GTPL7974
- CHEBI:135897
- GLXC-08066
- EX-A2216
- BDBM50174276
- s7091
- AKOS037645037
- CCG-270596
- CS-5715
- FZ28788
- NCGC00386351-01
- AC-31528
- AS-56346
- HY-12424
Look up ZOTAROLIMUS in the interactive SynDRA portal →